The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government.

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, an off-site outpatient facility of a covered entity (commonly referred to as a “child site”) must be reimbursable on the covered entity’s most recently filed Medicare cost report (MCR) and listed in the Office of Pharmacy Affairs Information System (OPAIS) as a child site of the covered entity.

There is no need to seek out ghosts, goblins, and ghouls for a fright this Halloween. Just look at the devilish 340B drug discount program.

Walgreens, the nation's largest drugstore chain, is reeling from labor shortages, executive turnover, fierce competition, debt issues, retail theft and now a worker walkout.

On October 26, the Health Resources and Services Administration (HRSA) issued a notice clarifying the registration requirements for offsite hospital outpatient facilities under the 340B drug pricing program.

Changes to registration requirements for the offsite clinics of 340B-eligible hospitals represent the latest clash between providers, regulators and drugmakers amid the program's exponential growth.

The first pillar of the AMA Recovery Plan for America's Physicians is reforming Medicare physician payment, and that push is more important than ever with impending Medicare pay cuts coming in 2024.

Hospitals place an unnecessary coronary stent in a Medicare beneficiary every seven minutes, costing taxpayers $800 million annually, according to a new analysis of claims data.

Physician participation in accountable care organizations (ACOs) and medical homes has grown steadily since 2014, even as fee for service remains the most prevalent payment method and revenue generated by alternative payment models has stagnated, according to the results of an AMA survey of about 3,500 physicians.

Two out of three physicians are concerned about AI driving diagnosis and treatment decisions, seeing it as a tool better suited for scheduling or other administrative tasks, according to a new Medscape survey.